Dashboard
Manage Tickers

VCNX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
04/25/2024 12:06:47

vaccinex-q4-eps-033-up-from-2310-yoy
Vaccinex Q4 EPS $(0.33) Up From $(23.10) YoY
04/03/2024 02:59:15

Vaccinex (NASDAQ:VCNX) reported quarterly losses of $(0.33) per share. This is a 98.57 percent increase over losses of $(23.10)...

vaccinex-expects-topline-data-for-phase-12a-randomized-signal-ad-study-of-pepinemab-for-alzheimers-disease-in-q3-2024
Vaccinex Expects Topline Data For Phase 1/...
04/02/2024 12:45:47

vaccinex-fy23-eps-4368-up-from-9805-yoy-revenue-570k-up-from-275k-yoy
Vaccinex FY23 EPS $(43.68) Up From $(98.05...
04/02/2024 12:44:53

vaccinex-inc-announces-15m-registered-direct-offering-and-concurrent-private-placement-priced-at-the-market-under-nasdaq-rules
Vaccinex, Inc. Announces $1.5M Registered ...
03/27/2024 12:31:27

vaccinex-announces-it-has-entered-into-eight-new-antibody-discovery-agreements-integrating-use-of-its-proprietary-activmab-platform-to-select-antibodies-against-difficult-to-drug-transmembrane-protein-targets
Vaccinex Announces It Has Entered Into Eig...
02/21/2024 13:21:19

Eight new antibody discovery agreements incorporate Vaccinex's powerful ActivMAb® Drug Discovery Platform ActivMab® platfor...

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
02/20/2024 13:55:04

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
02/17/2024 00:50:04

why-vaccinex-vcnx-stock-is-trading-lower
Why Vaccinex (VCNX) Stock Is Trading Lower
02/15/2024 14:31:43

Vaccinex shares are trading lower by 7.1%Thursday morning. The company announced a 1-for-14 reverse stock split.

vaccinex-inc-announces-1-for-14-reverse-stock-split
Vaccinex, Inc. Announces 1-For-14 Reverse ...
02/15/2024 13:06:16

Vaccinex, Inc., (NASDAQ:VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodeg...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
02/14/2024 21:31:06

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
02/09/2024 21:31:09

why-vaccinex-vcnx-stock-is-popping-off
Why Vaccinex (VCNX) Stock Is Popping Off
02/07/2024 16:09:19

Vaccinex shares are trading higher by 15% during Wednesday's session. The company announced a private placement transaction...

vaccinex-announces-pricing-of-37m-private-placement-for-the-sale-of-an-aggregate-3838544-shares-of-common-stock
Vaccinex Announces Pricing Of $3.7M Privat...
02/07/2024 13:08:16

accinex, Inc. (NASDAQ:VCNX) ("Vaccinex" or the "Company"), a clinical-stage biotechnology company pioneering a ...

nasdaq-grants-vaccinex-extension-until-march-4-2024-to-regain-compliance-with-listing-rule
Nasdaq Grants Vaccinex Extension Until Mar...
12/04/2023 13:09:00

vaccinex-q3-eps-109-up-from-165-yoy
Vaccinex Q3 EPS $(1.09) Up From $(1.65) YoY
11/13/2023 13:22:03

Vaccinex (NASDAQ:VCNX) reported quarterly losses of $(1.09) per share. This is a 33.94 percent increase over losses of $(1.65) ...

vaccinex-reports-clinical-benefit-in-interim-analyses-from-two-phase-2-studies-of-pepinemab-combination-treatment-at-society-for-immunotherapy-of-cancers-annual-meeting
Vaccinex Reports Clinical Benefit In Inter...
10/31/2023 13:13:05

Vaccinex, Inc. (NASDAQ:VCNX), a clinical-stage biotechnology company, will be reporting novel findings for its lead product, pe...

vaccinex-reports-effect-of-pepinemab-treatment-on-new-biomarker-of-brain-inflammation-in-neurodegenerative-diseases
Vaccinex Reports Effect Of Pepinemab Treat...
10/26/2023 13:31:39

Vaccinex, Inc. (NASDAQ:VCNX), a clinical-stage biotechnology company, today reports novel findings for its lead product, pepine...

on-oct-10-vaccinex-ot-letter-from-nasdaq-listing-staff-stating-that-co-has-not-regained-compliance-with-minimum-bid-price-standard
On Oct 10, Vaccinex ot Letter From Nasdaq ...
10/13/2023 21:03:08

- SEC Filing

vaccinex-13g-filing-shows-orin-hirschman-holds-99-passive-stake-in-co-as-of-september-28
Vaccinex 13G Filing Shows Orin Hirschman H...
10/11/2023 16:36:38

- SEC Filing

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION